AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $64.53
- 52-wk low
- $11.16
- Prev close
- $38.24
- Mkt cap
- $8.32B
- Fwd P/E
- 2000.0x
- Beta
- 2.04
Smart money
Earnings
Earnings came in 39.1% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $149.0M | $166.0M | $150.8M | $151.0M |
| Cost of what it sold | $48.7M | $53.0M | $44.7M | $38.5M |
| Gross profit | $100.3M | $113.0M | $106.2M | $112.5M |
| What it spent | ||||
| Research and development | $57.2M | $56.0M | $56.8M | $56.8M |
| Sales and admin | $75.4M | $76.6M | $66.4M | $78.7M |
| Other operating costs | — | — | — | -$3.4M |
| Total operating expenses | $132.5M | $132.6M | $123.2M | $132.1M |
| What was left | ||||
| Operating profit | -$32.2M | -$19.5M | -$17.0M | -$19.6M |
| Interest on debt | $3.0K | — | — | $0 |
| Profit before tax | -$28.2M | -$15.2M | -$12.8M | -$18.6M |
| Tax | -$733.0K | $1.1M | $623.0K | -$714.0K |
| Net profit | -$27.5M | -$16.3M | -$13.5M | -$17.9M |
| EBITDA | -$16.0M | $63.5M | -$937.0K | -$18.6M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
10 articles · 7 days
Coverage leans bearish
Tone of tracked coverage
10x Genomics (NASDAQ: TXG) director sells under 10b5-1 plan
Leans bearishAug 17ARK Investment Management (TXG) reports 10.0M-share position in 10x Genomics
NeutralAug 1510x Genomics Director John R. Stuelpnagel Sells 20,000 Shares in August 2026 SEC Filing
Leans bearishAug 13